Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT

NCT00350181 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma, Non-Hodgkin
Hematologic Diseases
Acute GVHD

Interventions

DRUG: Sirolimus
DRUG: MMF
DRUG: BCNU
DRUG: VP-16
DRUG: CY
DRUG: FTBI
DRUG: BU

Sponsor

Stanford University